BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31440985)

  • 1. Pro-inflammatory macrophage polarization enhances the anti-cancer efficacy of self-assembled galactomannan nanoparticles entrapped with hydrazinocurcumin.
    Kumari M; Purohit MP; Pahuja R; Patnaik S; Shukla Y; Kumar P; Gupta KC
    Drug Deliv Transl Res; 2019 Dec; 9(6):1159-1188. PubMed ID: 31440985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrazinocurcumin Encapsuled nanoparticles "re-educate" tumor-associated macrophages and exhibit anti-tumor effects on breast cancer following STAT3 suppression.
    Zhang X; Tian W; Cai X; Wang X; Dang W; Tang H; Cao H; Wang L; Chen T
    PLoS One; 2013; 8(6):e65896. PubMed ID: 23825527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles.
    Kumari M; Purohit MP; Patnaik S; Shukla Y; Kumar P; Gupta KC
    Eur J Pharm Biopharm; 2018 Sep; 130():185-199. PubMed ID: 29969665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin loading potentiates the chemotherapeutic efficacy of selenium nanoparticles in HCT116 cells and Ehrlich's ascites carcinoma bearing mice.
    Kumari M; Ray L; Purohit MP; Patnaik S; Pant AB; Shukla Y; Kumar P; Gupta KC
    Eur J Pharm Biopharm; 2017 Aug; 117():346-362. PubMed ID: 28499854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphiphilic galactomannan nanoparticles trigger the alternative activation of murine macrophages.
    Peled E; Sosnik A
    J Control Release; 2021 Nov; 339():473-483. PubMed ID: 34662585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
    Ray L; Kumar P; Gupta KC
    Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress, polarization of macrophages and tumour angiogenesis: Efficacy of caffeic acid.
    Oršolić N; Kunštić M; Kukolj M; Gračan R; Nemrava J
    Chem Biol Interact; 2016 Aug; 256():111-24. PubMed ID: 27378625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M3 Macrophages Stop Division of Tumor Cells In Vitro and Extend Survival of Mice with Ehrlich Ascites Carcinoma.
    Kalish S; Lyamina S; Manukhina E; Malyshev Y; Raetskaya A; Malyshev I
    Med Sci Monit Basic Res; 2017 Jan; 23():8-19. PubMed ID: 28123171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
    Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
    Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells.
    Pal S; Choudhuri T; Chattopadhyay S; Bhattacharya A; Datta GK; Das T; Sa G
    Biochem Biophys Res Commun; 2001 Nov; 288(3):658-65. PubMed ID: 11676493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages Reprogrammed In Vitro Towards the M1 Phenotype and Activated with LPS Extend Lifespan of Mice with Ehrlich Ascites Carcinoma.
    Kalish SV; Lyamina SV; Usanova EA; Manukhina EB; Larionov NP; Malyshev IY
    Med Sci Monit Basic Res; 2015 Oct; 21():226-34. PubMed ID: 26471744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
    Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
    Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the immune responses during the growth of Ehrlich's tumor in ascitic and solid form?
    Feitosa IB; Mori B; Teles CBG; Costa AGD
    Life Sci; 2021 Jan; 264():118578. PubMed ID: 33058910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy.
    Li JX; Shu N; Zhang YJ; Tong QS; Wang L; Zhang JY; Du JZ
    ACS Appl Mater Interfaces; 2024 May; 16(20):25665-25675. PubMed ID: 38735053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic anticancer efficacy of Bendamustine Hydrochloride loaded bioactive Hydroxyapatite nanoparticles: In-vitro, ex-vivo and in-vivo evaluation.
    Thomas SC; Sharma H; Rawat P; Verma AK; Leekha A; Kumar V; Tyagi A; Gurjar BS; Iqbal Z; Talegaonkar S
    Colloids Surf B Biointerfaces; 2016 Oct; 146():852-60. PubMed ID: 27455405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CaCO
    Yang S; Zhang Y; Lu S; Yang L; Yu S; Yang H
    ACS Appl Bio Mater; 2021 Apr; 4(4):3214-3223. PubMed ID: 35014408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein A-activated macrophages induce apoptosis in Ehrlich's ascites carcinoma through a nitric oxide-dependent pathway.
    Chattopadhyay S; Das T; Sa G; Ray PK
    Apoptosis; 2002 Feb; 7(1):49-57. PubMed ID: 11773705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin.
    Jaguin M; Houlbert N; Fardel O; Lecureur V
    Cell Immunol; 2013 Jan; 281(1):51-61. PubMed ID: 23454681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
    Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ
    Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma.
    Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV
    Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.